Chemical Component Summary | |
---|---|
Name | Fradafiban |
Synonyms | [(3S,5S)-5-{[(4'-carbamimidoyl[1,1'-biphenyl]-4-yl)oxy]methyl}-2-oxopyrrolidin-3-yl]acetic acid |
Identifiers | 2-[(3~{S},5~{S})-5-[[4-(4-carbamimidoylphenyl)phenoxy]methyl]-2-oxidanylidene-pyrrolidin-3-yl]ethanoic acid |
Formula | C20 H21 N3 O4 |
Molecular Weight | 367.398 |
Type | NON-POLYMER |
Isomeric SMILES | [H]/N=C(\c1ccc(cc1)c2ccc(cc2)OC[C@@H]3C[C@H](C(=O)N3)CC(=O)O)/N |
InChI | InChI=1S/C20H21N3O4/c21-19(22)14-3-1-12(2-4-14)13-5-7-17(8-6-13)27-11-16-9-15(10-18(24)25)20(26)23-16/h1-8,15-16H,9-11H2,(H3,21,22)(H,23,26)(H,24,25)/t15-,16-/m0/s1 |
InChIKey | IKZACQMAVUIGPY-HOTGVXAUSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 48 |
Chiral Atom Count | 2 |
Bond Count | 50 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB06472 |
---|---|
Name | Fradafiban |
Groups | investigational |
Synonyms | Fradafiban |
Indication | Investigated for use/treatment in angina. |
Categories |
|
CAS number | 148396-36-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Integrin alpha-IIb | MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQF... | unknown | |
Integrin beta-3 | MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCA... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 66000 |
ChEMBL | CHEMBL3085474 |
ChEBI | CHEBI:73266 |